These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8262007)

  • 1. Steroid 5 alpha-reductase 2 deficiency.
    Wilson JD; Griffin JE; Russell DW
    Endocr Rev; 1993 Oct; 14(5):577-93. PubMed ID: 8262007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Alpha reductase deficiency: a 40-year retrospective review.
    Okeigwe I; Kuohung W
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):483-7. PubMed ID: 25321150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural potent androgens: lessons from human genetic models.
    Zhu YS; Katz MD; Imperato-McGinley J
    Baillieres Clin Endocrinol Metab; 1998 Apr; 12(1):83-113. PubMed ID: 9890063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of external genitalia and 5 alpha-reductase].
    Tohda A; Matsumoto F; Shimada K; Okuyama A
    Nihon Rinsho; 2004 Feb; 62(2):275-80. PubMed ID: 14968532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
    Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
    J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.
    Jenkins EP; Andersson S; Imperato-McGinley J; Wilson JD; Russell DW
    J Clin Invest; 1992 Jan; 89(1):293-300. PubMed ID: 1345916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity.
    Imperato-McGinley J; Peterson RE; Gautier T; Sturla E
    J Steroid Biochem; 1979 Jul; 11(1B):637-45. PubMed ID: 491628
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
    Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
    Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid 5α-reductase 2 deficiency.
    Mendonca BB; Batista RL; Domenice S; Costa EM; Arnhold IJ; Russell DW; Wilson JD
    J Steroid Biochem Mol Biol; 2016 Oct; 163():206-11. PubMed ID: 27224879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency.
    Imperato-McGinley J; Zhu YS
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):51-9. PubMed ID: 12573814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of DNA analysis in the diagnosis of steroid 5-alpha-reductase deficiency].
    Kostyrko A; Antkowiak J; Warenik-Szymankiewicz A; Trzeciak WH
    Ginekol Pol; 1994 Jul; 65(7):400-6. PubMed ID: 8001864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the testicular abnormality in 5 alpha-reductase deficiency.
    Johnson L; George FW; Neaves WB; Rosenthal IM; Christensen RA; Decristoforo A; Schweikert HU; Sauer MV; Leshin M; Griffin JE
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1091-9. PubMed ID: 3760113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
    Imperato-McGinley J
    Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.
    Andersson S; Berman DM; Jenkins EP; Russell DW
    Nature; 1991 Nov; 354(6349):159-61. PubMed ID: 1944596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency.
    Hiort O; Willenbring H; Albers N; Hecker W; Engert J; Dibbelt L; Sinnecker GH
    Eur J Pediatr; 1996 Jun; 155(6):445-51. PubMed ID: 8789759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of testosterone binding to the androgen receptor in male sexual differentiation of patients with 5 alpha-reductase deficiency.
    Maes M; Sultan C; Zerhouni N; Rothwell SW; Migeon CJ
    J Steroid Biochem; 1979 Oct; 11(4):1385-92. PubMed ID: 513759
    [No Abstract]   [Full Text] [Related]  

  • 18. Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management.
    Mendonca BB; Inacio M; Costa EM; Arnhold IJ; Silva FA; Nicolau W; Bloise W; Russel DW; Wilson JD
    Medicine (Baltimore); 1996 Mar; 75(2):64-76. PubMed ID: 8606628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature.
    Imperato-McGinley J
    Adv Exp Med Biol; 2002; 511():121-31; discussion 131-4. PubMed ID: 12575759
    [No Abstract]   [Full Text] [Related]  

  • 20. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation.
    Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.